About AmpTec
AmpTec is a company based in Hamburg (Germany) founded in 2005 by Guido Krupp and Peter Scheinert was acquired by Merck in January 2021. AmpTec operates in a competitive market with competitors including ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others.
- Headquarter Hamburg, Germany
- Founders Guido Krupp, Peter Scheinert
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AmpTec
Investors in AmpTec
AmpTec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Merck and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Merck is engaged in science and technology solutions globally.
|
Locked | Locked | Locked |
Investor details for AmpTec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AmpTec
Investment portfolio details for AmpTec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AmpTec
Detailed financials for AmpTec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amptec Comparisons
Peer comparison for AmpTec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AmpTec
AmpTec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Inscripta, GenScript, OncoDNA and Sino Biological, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
Detailed competitors of AmpTec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amptec
Complete news archive for AmpTec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AmpTec
AmpTec was founded in 2005 and raised its 1st funding round 15 years after it was founded.
AmpTec is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Peter Scheinert is the current CEO of AmpTec. They have also founded this company.
AmpTec was founded in 2005 and is based in Hamburg, Germany. Operations focus on the biotechnology sector, where RNA isolation kits, mRNA amplification kits, guide RNAs for CRISPR applications, synthetic long RNAs and DNAs, and functional mRNAs are developed and distributed. The portfolio supports research in RNA-related fields through these specialized offerings.
AmpTec's top competitors include Sino Biological, OncoDNA and ArcherDX.
AmpTec has 2 investors. Key investors include Merck, and European Union.